Creative Biolabs-Immuno-oncology

Anti-CD40 (clone BE-1G) SynExpress C-BF-I4-K Modified CD8+ T cells (CAT#: ITS-1224-CR1533)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD40 (clone BE-1G). We employs the HBV (CMV-BFP-IL-4-KpnI) vector components and the SynExpress system of the miRNA Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD40
Clone
BE-1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.92
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.